Wednesday, August 5, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Artificial Intelligence

Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder

November 20, 2024
in Artificial Intelligence, Press Release
Reading Time: 4 mins read
5
SHARES
248
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

New York, NY, November 19, 2024 –(PR.com)– TrialX, a leader in building enterprise clinical trial patient recruitment and remote clinical research data collection platforms, announces a strategic partnership with Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes. The collaboration aims to enhance the availability of clinical trial information for the pancreatic cancer patients and caregivers.

“We are excited to partner with Let’s Win Pancreatic Cancer to make clinical trials more accessible to patients and families,” said Paul Donnelly, Chief Strategy Officer, TrialX. “Clinical trials are a crucial avenue for patients to explore potential new treatments, and we are honored to support Let’s Win in their mission to provide pancreatic cancer patients with easy access to the most up-to-date knowledge about the disease in English and Spanish, including state-of-the-art online clinical trial matching capabilities.” TrialX’s global clinical trial finder was selected to power Let’s Win’s Trial Finder, an essential resource to help pancreatic cancer patients and caregivers easily find clinical trial information.

While clinical trials registries like ClinicalTrials.gov provide information on ongoing or completed clinical trials conducted in the United States and globally, the database can be challenging to search for relevant trials. Additionally, the way trial information is presented may be difficult for many individuals who could benefit from clinical trials as a treatment option to understand. With Let’s Win’s Trial Finder, individuals interested in clinical trial participation can now receive personalized trial results based on their location and health history. Our AI-guided search process, powered by a series of tailored questions, ensures precise matches to enhance trial accessibility and suitability. Moreover, the pancreatic cancer community will have access to bilingual navigators fluent in English and Spanish, offering direct, empathetic support in finding matching clinical trial opportunities.

“Pancreatic cancer patients face an overwhelming number of decisions in their treatment journey. Our mission at Let’s Win is to make sure patients don’t face these decisions alone, and our new Trial Finder is the most advanced resource, based on technology trusted by other large advocacy groups, that can help identify opportunities for cutting-edge treatment,” said Cindy Gavin, CEO and Co-founder of Let’s Win Pancreatic Cancer. “By partnering with TrialX, we’re ensuring that patients have access to the latest clinical trials in a way that’s simple and actionable.”

About TrialX
TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is on a mission to facilitate One Billion Health Research Contributions. TrialX products include an award-winning patient recruitment management platform, a remote research data collection (ePRO/eCOA) platform and an online talk show, all designed to facilitate access and participation in clinical research. TrialX products are used by Top 5 Pharma and other clinical trial sponsors, leading academic medical centers such as the University of Pennsylvania and patient advocacy groups such as The Michael J. Fox Foundation for Parkinson’s Research (MJFF), Sickle Cell Disease Association of America, International Rett Syndrome Foundation, the Reflections initiative, the Alzheimer’s Association and the Global Lyme Alliance. To learn more, visit https://trialx.com/.

About Let’s Win Pancreatic Cancer
Let’s Win is a go-to resource that guides patients and caregivers with vital information for better outcomes. Through a dynamic online platform available in English and Spanish, everyone who is diagnosed with pancreatic cancer—or individuals at higher risk—can have easy access to the most up-to-date knowledge about the disease. Let’s Win has become a trusted resource for the pancreatic cancer community, providing a wealth of readily accessible, easily understandable, and medically vetted resources to give pancreatic cancer patients and their caregivers a clear path for action as well as much-needed hope. Let’s Win! Pancreatic Cancer is a 501(c)(3) organization and is an affiliate of the Lustgarten Foundation. To learn more, visit https://letswinpc.org.

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
ShareTweet1ShareSendShare2
Previous Post

The Anti-Money Laundering Systems Market to Achieve USD 72.82 Billion by 2032 with a Robust 9.89% CAGR

Next Post

Blockchain Technology Company BlackStar Sees Future of Digital Asset Trading

Related Posts

Optex Systems Holdings Announces Third Quarter Earnings Call

RICHARDSON, TX / ACCESS Newswi e / August 5, 2026 / Optex Systems Holdi gs, I c. (Nasdaq:OPXS), a ma ufactu e of p ecisio optical sighti g systems fo milita y a d comme cial applicatio s, a ou ced today that it pla s to epo t its...

Read moreDetails

NX3 Commercial Group Completes $15 Million Multi-Property 1031 Exchange Across Florida and Texas

Josh Fe ito P omoted to Vice P eside t, I vestme t Sales Team Followi g $20 Millio i 2026 Closed Volume FORT LAUDERDALE, FL / ACCESS Newswi e / August 5, 2026 / NX3 Comme cial G oup a ou ced today the successful completio of a app...

Read moreDetails

Trustifi Launches Collaboration Platform to Close the MS 365 Gaps for MSPs and Their Clients

Cha el-Fi st Secu ity I ovato Now Offe s Cha el Pa t e s G eate Ove sight, Co t ol a d P otectio Ac oss Teams, O eD ive a d Sha ePoi t Key Takeaways T ustifi Collabo atio Shield is a secu ity platfo...

Read moreDetails

ClearSign Technologies Corporation Announces Second Quarter 2026 Conference Call

Hosti g Call at 5pm ET o Wed esday, August 19th TULSA, OK / ACCESS Newswi e / August 5, 2026 / Clea Sig Tech ologies Co po atio (NASDAQ:CLIR) ("Clea Sig " o the "Compa y"), a leade i adva ced combustio a d se si g tech ologies...

Read moreDetails

Ondas Secures U.S. Army Order for Lethal Unmanned Systems for Over $50 Million

Rep ese ts a additio al o de fo O das' Mist al I c. u de a p eviously awa ded $982 millio multi-yea IDIQ suppo ti g the U.S. A my's Lethal U ma ed Systems (LUS) p og am O de st e gthe s O das'...

Read moreDetails

DataMeds AI to be Featured In-Person on Fox Business’ Claman Countdown to Introduce “Health Lives Here”

I itiative with NFL Alum i Health is aimed at imp ovi g u al healthca e access by powe i g Health Lives He e co sume app that i teg ates Ei stei AI with i depe de t pha macies a d p op ieta y patie...

Read moreDetails

Egnyte Launches AI-Powered Workflow Automation With Built-In Governance to Help Organizations Scale Efficiently and Securely

MOUNTAIN VIEW, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Eg yte, a leade i secu e co te t collabo atio , i tellige ce, a d gove a ce, today a ou ced ew AI-powe ed wo kflow automatio capabilities. These capabilities help o ga izatio s ove come...

Read moreDetails

Talos Integrates with STS Digital to Bring Institutional Crypto Options and Spot Liquidity to its Provider Network

Hamilto , Be muda, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STS Digital Ltd., a Be muda- egulated p i cipal t adi g fi m specialized i digital asset de ivatives a d st uctu ed p oducts, today a ou ced that its i stitutio al optio s a...

Read moreDetails

Rocket Doctor AI joins the B2i Digital Featured Company Program and its Network of more than 1.7 million Retail and Institutional Market Participants

VANCOUVER, B itish Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Rocket Docto AI I c. (CSE: AIDR, OTC: AIRDF, F a kfu t: 939) (“Rocket Docto AI” o the “Compa y”) has e te ed i to a digital adviso y ag eeme t (the “Ag eeme t”) to etai...

Read moreDetails

Autonomize AI Launches Fraud, Waste, and Abuse AI-native App in the ServiceNow Store

AUSTIN, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Auto omize AI today a ou ced the availability of Auto omize Payme t I teg ity-FWA, a AI-powe ed healthca e claims eview applicatio i the Se viceNow Sto e. Built atively o the Se viceNow Healthca e a d Life...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Top Cross-Chain DeFi Solutions to Watch by 2025

    178 shares
    Share 71 Tweet 45
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    181 shares
    Share 72 Tweet 45
  • Understanding Soulbound Tokens SBT Their Definition and Significance

    76 shares
    Share 30 Tweet 19
  • Top 5 Wallets for Seamless Multi-Chain Trading in 2025

    95 shares
    Share 38 Tweet 24
  • Top Layer 1 Crypto Projects to Watch in 2025

    32 shares
    Share 13 Tweet 8
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Optex Systems Holdings Announces Third Quarter Earnings Call
  • NX3 Commercial Group Completes $15 Million Multi-Property 1031 Exchange Across Florida and Texas
  • Trustifi Launches Collaboration Platform to Close the MS 365 Gaps for MSPs and Their Clients
  • ClearSign Technologies Corporation Announces Second Quarter 2026 Conference Call
  • Ondas Secures U.S. Army Order for Lethal Unmanned Systems for Over $50 Million

RSS Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.